We next inhibited HIF-1α and NLRP3 by intra-thalamic injection of YC-1 (HIF-1α inhibitor) and MCC950 (NLRP3 inhibitor) and assessed mechanical pain sensitivity and anxiety- and depression-like behaviors (Fig. 4A). Here, HIF1A is linked to major depressive disorder.